Exabis Library
Welcome to the e-CCO Library!
P606: Intestinal fatty acid binding protein parallels temporal changes in Harvey-Bradshaw Index and TNFα in response to infliximab in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P606: Significant regional differences in referral patterns for bowel resection in Crohn's disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P606: Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P606: Use of TNF-α-antagonists and systemic steroids is associated with attenuated immunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P607 Cost-effectiveness of vedolizumab IV vs. adalimumab SC for moderately to severely active ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P607: Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade®) to the biosimilar SB2 (Flixabi®) in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P607: Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P607: Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P607: HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P607: Post-operative mortality and predictive factors in a cohort of severe refractory ulcerative colitis patients from the ENEIDA Registry (1989–2013): a multicenter nationwide study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P607: The Faroese IBD Study: Update on incidence from 2015-2020 and prevalence from 1960-2020
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P608 Endoscopic treatment of enterocutaneous fistulas in Crohn’s disease patient
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P608: Crohn’s disease patients with high baseline symptoms achieve clinical remission more rapidly with Budesonide than with Mesalazine
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P608: Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P608: IV iron treatment of iron deficiency anaemia with ferumoxytol in patients with inflammatory bowel disease unable to take oral iron: A randomised controlled trial vs. ferric carboxymaltose
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P608: New anti-migration extractible metal stents for Crohn's disease strictures: a nationwide GETAID-SFED cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P608: Systematic review: The impact and importance of body composition in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P608: Time to onset of effect of biologics and small molecules in moderate-to-severe or acute severe ulcerative colitis – a systematic review and network meta-analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P609 An IBD dermatology multidisciplinary clinic: A single tertiary centre experience
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P609: A treat-to-target approach via a virtual clinic amongst inflammatory bowel disease patients with secondary loss of response to anti-TNF therapy improves clinical outcomes
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM